Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale  by Dark, Michael J. et al.
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Anaplasmosis  in  domestic  livestock  is an  impediment  to animal  health  and  production  worldwide,  espe-
cially  in  developing  countries  in  Africa,  Asia,  and  South  America.  Vaccines  have  been  developed  and
marketed  against  the  causative  organism,  Anaplasma  marginale;  however,  these  have  not  been widely
used  because  of  breakthrough  infections  caused  by  heterologous  strains  and  because  of  the risk  of  disease
induced  by  live  vaccine  strains  themselves.  Recently,  molecular  studies  have  enabled  progress  to  be made
in  understanding  the  causes  for  breakthrough  infections  and  in  deﬁning  new  vaccine  targets.  A.  marginale
has  a system  for  antigenic  variation  of  the  MSP2  and  MSP3  outer  membrane  proteins  which  are  members
of  the  pfam01617  gene  superfamily.  In this  study,  we  used  high  throughput  genome  sequencing  to deﬁne
conservation  of  different  superfamily  members  in  ten  U.S.  strains  of  A. marginale  and  also  in the  related
live  vaccine  strain  A. marginale  subspecies  centrale.  The  comparisons  included  the pseudogenes  that  con-acteria tribute  to antigenic  variation  and  other  superfamily-encoded  outer  membrane  proteins.  Additionally,  we
examined  conservation  of  other  proteins  proposed  previously  as  vaccine  candidates.  These data  showed
signiﬁcantly  increased  numbers  of SNPs  in  A.  marginale  subspecies  centrale  when compared  to all  U.S.  A.
marginale  strains.  We  deﬁned  a catalog  of 19  conserved  candidate  vaccine  antigens  that  may  be  suitable
for  development  of  a  multi-component  recombinant  vaccine.  The  methods  described  are  rapid  and  may
be  suitable  for  other  prokaryotes  where  repeats  comprise  a  substantial  portion  of  their genomes.. Introduction
Anaplasma marginale is a pathogen of cattle in the Order
ickettsiales, causing cyclic anemia and occasionally death. The
rganism causes severe economic losses in livestock produc-
ion worldwide [1]. Various strategies have been implemented to
evelop a vaccine to mitigate the impact of this disease. The ﬁrst
ttempt at a vaccine was in the early 1900s, with the isolation of
. marginale subspecies centrale, a less virulent strain that gives
ome cross-protection to fully virulent strains [2]. Other vaccine
ttempts have included a variety of subunit vaccines, none of which
rovided complete protection against heterologous challenge [3,4].
n addition, while infection with one strain of A. marginale sensu
tricto typically precludes infection with another, multiple cases of
uperinfection have been described [5–7].
Abbreviations: omp, outer membrane protein; msp, major surface protein; SNP,
ingle nucleotide polymorphism.
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Vaccine failures are due to expression of variants of the major
surface proteins MSP2 and MSP3. A. marginale creates a wide
array of antigenic variants by substitution of whole or partial
pseudogene cassettes into a single genomic expression site by
segmental gene conversion [8–11], with increasing complexity of
the expressed mosaic proteins [12]. Following persistent infec-
tion, the immune system has been exposed to a majority of
the simple variants, which prevents another strain with similar
variants from establishing concurrent infection. However, if the
second strain has a unique pseudogene, novel variants generated
by segmental gene conversion allow superinfection to take place
[13].
In addition to MSP2 and MSP3, a variety of other variable sur-
face antigens have been found in A. marginale; these have been
called the msp2 superfamily [14]. Generally, these are all members
of the pfam01617 (Surface Ag 2), which has related members in
several other bacterial genera. Several of these have been found in
cross-linked surface antigen complexes, and have been suggested
as vaccine candidates [15]. A recent study by Agnes et al. used sera
Open access under CC BY license.from cattle infected with A. marginale subspecies centrale to deter-
mine antigens that are cross-protective from sensu stricto challenge
[16]. Several other studies have implicated components of the bac-
terial type 4 secretion system as vaccine candidates [17–19].
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In this paper, we examine multiple strains of A. marginale sensu
tricto, using high-throughput sequencing techniques to examine
he members of the pfam01617 family and the other previously
uggested vaccine components to determine their degree of con-
ervation. Proteins that are widely conserved between all strains
re candidates for inclusion in cross-protective vaccines. Further,
he techniques described can be used to examine other organisms
ith signiﬁcant numbers of repeats, allowing rapid determination
f conserved proteins for diagnosis and vaccine development.
.  Materials and methods
.1.  DNA isolation and genome sequencing
A. marginale genomic DNA was isolated from highly infected
ovine blood taken at the acute stage of infection. Organisms were
uriﬁed from uninfected erythrocytes and white cells by passage
hrough a cellulose column (C-6288, Sigma, St. Louis, MO)  and
rozen [20]. Genomic DNA was isolated from organisms using Qia-
en genomic DNA kits according to manufacturer protocols. To
ompare genomes of Florida and Florida-relapse strains bovine
205 was infected with the Florida strain and experienced max-
mum acute stage parasitemia of 4% on day 37 post-infection and
 minimum packed cell volume (pcv) of 18.5% which resolved
o the carrier state, with pcv values returning to 35% and no
icroscopically detectable parasitemia. Bovine #205 was  kept in
solation and splenectomized on day 104 post-infection to allow
isease recrudescence. Infected blood from the Florida-relapse
train was obtained on day 129 post-infection at 22.5% parasitemia
nd 23% pcv. A. marginale strains analyzed in the present study
ere Puerto Rico, Mississippi, Virginia, Florida, Florida-relapse,
lorida-Okeechobee, St. Maries-Idaho, South Idaho, Oklahoma and
ashington-O. Isolated DNA was provided to the Interdisciplinary
enter for Biotechnology Research (ICBR) core facilities, University
f Florida for library construction and sequencing on the Roche/454
enome Sequencer according to standard manufacturer protocols.
he SFF format ﬂow ﬁles were returned by ICBR for bioinformatics
nalysis..2. Bioinformatics
MosaikAligner was used to align individual reads with the
eference genome sequences [21]. The SFF ﬂow ﬁles were ﬁrst
able 1
omparison of msp2 and msp3 genes between pyrosequenced and Sanger-sequenced An
re shown together with their % sequence identity (of the best match, by MATGAT), in p
90% sequence identity between strains were detected as absent. Mean genome coverag
Florida,  StM – St. Maries, ACIS – A. marginale subspecies centrale, Israel.
FL msp2 StM msp2 
Pyro
Annot. 25 47 155 534 757 872 945 1018 33 49 21
FL  (100) (100) (100) (100) (100) (100) (100) (100) (99) (92) (7
59X  + + + + + + + + + + −
FL-rel
76X  + + + + + + + + + + −
StM  (99) (92) (90) (92) (100) (100) (100) (91) (100) (100) (1
117X  + + − + + + + − + + + 
FL msp3 StM msp3 
Pyro
Annot. 34 58 65 533 871 1019 1097 47 62 78 91
FL  (100) (100) (100) (100) (100) (100) (100) (100) (60) (57) (7
59X  + + + + + + + + − − −
FL-rel
76X  + + + + + + + + − − −
StM (59) (56) (68) (100) (97) (55) (100) (100) (100) (100) (1
117X  − − − + + − + + + + +  (2011) 4923– 4932
combined  and converted to .fasta and .qual ﬁles using Roche/454
Genome Sequencer FLX System software, version 2.3. MosaikBuild
(http://code.google.com/p/mosaik-aligner/) was  used to convert
reads and the reference sequences to the Mosaik binary format
(.dat ﬁles). The alignment parameters were: hash size (−hs), 11;
maximum percentage of the read length allowed to be errors
(−mmp), 0.05; alignment candidate threshold (−act), 20; align-
ment mode (−m),  all. The reference genomes were A. marginale
St. Maries, Idaho strain, GenBank CP000030; A. marginale Florida
strain, CP001079 and A. marginale subspecies centrale Israel strain,
CP001759. MosaikText was  used to convert the aligned binary data
ﬁle to the text-based BAM format (−bam) and samtools [22] to
sort and index the BAM ﬁle for viewing in Artemis [23,24]. Artemis
allows viewing of the alignment of individual reads either zoomed
in to detect gaps in alignment with respect to the annotated ref-
erence sequence or zoomed out to show SNPs over large genome
regions. For these analyses, two  corrections were made to the Gen-
Bank annotations:
1. An  msp3 pseudogene is not annotated in CP001079, complement
#46310–47887. This was annotated here as AMF  1097;
2. In  CP000030, an msp3 pseudogene, AM1345, is incorrectly anno-
tated  as #1181002–1182983. This was  corrected to complement
#1181022–1183055, retaining the designation of AM1345.
To deﬁne the sensitivity for detecting variant genes by Mosaik
alignments, we  extracted all variable regions for msp2 and msp3
pseudogenes from the three fully sequenced genomes and com-
pared their sequence identities. This was done in an all-against-all
analysis of the 22 total msp2 pseudogenes and 22 total msp3 pseu-
dogenes in the three sequenced genomes using a MATGAT matrix
[25]. From this analysis we  determined that the closest matches
for variable regions of msp2 pseudogenes in heterologous genomes
ranged from 100 to 73% identity and was 100 to 52% identity for
msp3 pseudogenes (see Table 1). We  deﬁned the variable regions as
the sequence encoding LGKELAY to MAGNIN for msp2 pseudogenes
and that encoding LETEEL to KNRG for msp3 pseudogenes. These
sequences vary slightly between pseudogenes, for example is more
typically LQAEEI to KNRG for msp3 pseudogenes from A. marginale
subspecies centrale, but the locations can readily be identiﬁed by
alignment. Comparing pyrosequencing data to all the known msp2
and msp3 genes showed that all msp2 pseudogenes with the best
match in the heterologous strain below 92% variable region iden-
aplasma genomes. Genes detected as present (+) or absent (−) by pyrosequencing
arentheses. The respective gene annotations are shown at the top. All genes with
e for pyrosequencing data is indicated in the left column. Genome abbreviations: FL
ACIS msp2
3 720 1152 1250 1344 29 47 50 145 601 1176 1183
8) (92) (100) (100) (100) (79) (76) (79) (75) (81) (79) (77)
 + + + + − − − − − − −
 + + + + − − − − − − −
00) (100) (100) (100) (100) (78) (74) (78) (73) (80) (79) (77)
+ + + + − − − − − − −
ACIS msp3
 718 1150 1345 70 144 298 354 393 1076 1173 1180
6) (100) (97) (78) (58) (58) (59) (54) (57) (52) (60) (59)
 + + − − − − − − − − −
 + + − − − − − − − − −
00) (100) (100) (100) (59) (58) (59) (53) (61) (52) (60) (59)
+ + + − − − − − − − −
M.J. Dark et al. / Vaccine 29 (2011) 4923– 4932 4925
Fig. 1. Diversity in msp2/msp3 gene pairs between A. marginale strains. Top panel, pyrosequences of Florida strain compared with the msp2/msp3 gene pair AMF  871/872 of
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air  AMF  1018/1019 of the Florida strain genome. Both genes are deﬁned as absent
ity were detected as absent (−) and all msp3 pseudogenes with
elow 97% variable region identity were detected as absent (−)
Table 1). Since the Mosaik alignment parameter −mmp  allows a
% error in aligning reads, we conservatively estimate that variant
enes are detected as absent if they have <90% identity, but may
ot be detected as absent if they have >90% identity. In this study
e examined the presence or absence of the pfam01617 super-
amily including genes encoding OMPs 1 through 15, OPAG1-3 and
SP4 [14,26]; proteins identiﬁed by surface cross-linking includ-
ng their encoding genes AM366, 712, 779, 780, 854, 1011, 1051
15]; and type 4 secretion system genes AM030, 097, 810, 811, 812,
13, 814, 815, 1053, 1312, 1313, 1314, 1315, 1316 [19]. Numbering
efers to annotations of the St. Maries, Idaho strain, CP000030. To
e deﬁned as conserved in A. marginale in Table 4 no segment of the
enes was detected as absent in any comparisons of pyrosequenced
ata from each of 10 U.S. strains of A. marginale with the fully
equenced genomes of Florida and St. Maries, Idaho strains. Pyrose-
uencing data was previously obtained for A. marginale strains
uerto Rico, Mississippi and Virginia and in the present study for
. marginale strains Florida, Florida-relapse, Florida-Okeechobee,
t. Maries-Idaho, South Idaho, Oklahoma and Washington-O. The
verage genome coverages were 40×, 12×, 63×, 59×, 76×, 47×,
17×, 37×, 96×, and 108× for the ten strains, respectively, whenyrosequences of Florida strain compared with msp2/msp3 gene pair AM1344/1345
 panel, pyrosequences of St. Maries, Idaho strain compared with msp2/msp3 gene
compared to the completed genome from the Florida strain. Since
we did not have current access to the Mississippi strain and cov-
erage was lower for this strain, we  also veriﬁed that no gene was
determined as not conserved solely because of absence in this one
strain.
The number of high conﬁdence differences between strains
(Table 3) was analyzed using Roche/454 gsMapper software to
generate the 454HCDiffs.txt ﬁle. The base differences and their loca-
tions were extracted with the unix grep command and imported
into Excel 2008 (Microsoft, Redmond, WA). The number of differ-
ences and their respective frequencies (the percentage of different
reads versus total reads that fully span the difference location) were
tabulated.
Finally, for coverage and SNP analyses in Fig. 4 and Table 5, the
BAM ﬁles generated by Mosaik were processed by samtools ver-
sion 0.12 to generate pileups. Pileups for genes of interest were
extracted to determine coverage for each nucleotide position com-
paring to both the Florida and St. Maries strains. Final coverages for
each gene of interest were graphed using Excel 2008. For SNP analy-
sis, raw SFF ﬁles were processed by Genomics Workbench (CLC Bio,
Aarhus, Denmark), and the output of the SNP identiﬁcation pipeline
was placed into a MySQL database. To increase the stringency of
SNP identiﬁcation, the database was queried for SNPs identiﬁed by
4926 M.J.  Dark et al. / Vaccine 29 (2011) 4923– 4932
Table  2
Shared msp2 and msp3 pseudogenes between U.S. A. marginale strains and A. marginale subspecies centrale (Israel strain). No pseudogenes are shared between any of
ten  U.S. marginale strains and centrale. The repertoire of both msp2 and msp3 pseudogenes is diverse in U.S. marginale strains. Strain abbreviations: FL – Florida, WA-O –
Washington-Okanagan, OK – Oklahoma, VA – Virginia, MS  – Mississippi, SI – South Idaho, StM-I – St. Maries, Idaho, ACIS – A. marginale subsp. centrale, Israel.
FL msp2 FL msp3 StM-I msp2 StM-I msp3 ACIS msp2 ACIS msp3
FL 8/8  7/7 6/7 3/7 0/7 0/8
FL-relapse  8/8 7/7 6/7 3/7 0/7 0/8
FL-Okeechobee 4/8 2/7 3/7 2/7 0/7 0/8
WA-O  2/8 0/7 2/7 0/7 0/7 0/8
OK  1/8 1/7 0/7 0/7 0/7 0/8
VA  6/8 2/7 4/7 2/7 0/7 0/8
MS 1/8 0/7 2/7 0/7 0/7 0/8
Puerto  Rico 8/8 3/7 6/7 2/7 0/7 0/8
SI 2/8  0/7 2/7 0/7 0/7 0/8
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amtools, and only SNPs identiﬁed by both methods are included
n the ﬁnal analysis.
.  Results
.1. Comparison of pyrosequencing with Sanger sequencing
Two complete genome sequences of A. marginale strains from
he United States (Florida and St. Maries, Idaho) and one of A.
arginale subspecies centrale (Israel) are available [14,26,27]. We
nalyzed high-throughput sequencing data from the Roche/454
nstrument on 10 U.S. A. marginale strains, including the previ-
usly genome-sequenced Florida and St. Maries strains as controls.
ncluding Florida and St. Maries strains enables a comparison to
e made between the new pyrosequencing data and data obtained
sing Sanger sequencing. We  included in this comparison a sec-
nd Florida strain (Okeechobee) and a second Idaho strain (South
daho). We  also included a Florida relapse strain derived from a
ersistently infected animal after 129 days of infection, to examine
enome changes over a short time period.
The initial analyses compared the original genome sequences
ith the new pyrosequencing data. This was done by aligning indi-
idual pyrosequenced reads with the completed genomes using
osaik, with visualization of the ﬁnished alignments using Artemis.
o deal with the known problem of multiple repeats in these
enomes, the alignment parameters were set to allow reads to
lign at multiple different positions in the genome, if this was  nec-
ssary. A typical result showing alignments with msp2 and msp3
enes is shown in Fig. 1. The top panel shows alignment of Florida
train pyrosequencing data with a region of the Florida genome
ontaining an msp2/msp3 gene pair (AMF 871/872). The reads align
ver the complete msp2 and msp3 regions, as expected. In the mid-
le panel, a comparison is made between the same Florida strain
able 3
umbers of high conﬁdence differences between Anaplasma strain genomes (gsMapper so
overing  the respective regions, 100% frequency) are shown. Excluding homologous comp
etween A. marginale strains and 23,984 between A. marginale strains and A. marginale su
Pyrosequencing data vs. FL vs. St
Total @100% frequency Total
FL 105 38 751
FL-relapse  122 37 769
FL-Okeechobee 8747 5000 855
WA-O 9632 6240 911
OK  11,333 6635 11,66
VA  4932 2368 809
MS 8064  5522 750
Puerto  Rico 3217 2816 716
SI 9132  6487 827
StM-I  7747 5577 197/7 0/7 0/8
pyrosequencing data but with a region of the St. Maries, Idaho strain
genome encompassing the msp2/msp3 gene pair AM1344/1345. In
this case, the previously obtained genome data shows that AM1344
has an exact match (100% identity) with an msp2 copy in the Florida
strain genome, but the closest match of the St. Maries msp3 copy
AM1345 is to an msp3 copy in the Florida strain with only 78% iden-
tity (Table 1). This is revealed by a gap in the aligning sequence reads
over the central (hypervariable) region of AM1345, but no gap over
AM1344. The lowest panel shows an extreme case where neither
the msp2 (AMF 1018) nor the msp3 (AMF 1019) pseudogene from
the Florida strain aligns with reads from St. Maries. Comparison of
the two genome sequences reveals closest matches between the
two genomes of 91% for AMF  1018 and 55% for AMF  1019. This
analysis was conducted for all msp2 and msp3 copies in the three
genomes, A. marginale (Florida strain), A. marginale (St. Maries,
Idaho strain) and A. marginale subspecies centrale (Israel strain).
The data revealed that all msp2 and msp3 differences with <90%
identity were accurately detected (Table 1).
3.2. Genome diversity of Anaplasma sp.
We then compared the msp2 and msp3 pseudogenes in all 10
U.S. strains of A. marginale and A. marginale subspecies centrale, by
the same method (Table 2). The results showed that no msp2 or
msp3 pseudogene from any of these strains of A. marginale from
the United States was shared with A. marginale subspecies cen-
trale. Indeed, there was  substantial variation in the repertoire of
the msp2 and msp3 pseudogenes even within U.S. A. marginale
strains, with no msp2 or msp3 copy shared between Oklahoma
and St. Maries, Idaho strains and only one of each shared between
Oklahoma and Florida strains. Interestingly, there was substan-
tial variation even between strains from the same state, with no
msp3 pseudogene shared between the two strains from Idaho
and only two  msp3 pseudogenes shared between the two strains
ftware). Total differences as well as non-polymorphic differences (found in all reads
arisons (FL, FL-relapse, St. Maries, Idaho), there are an average of 5302 differences
bspecies centrale. Strain abbreviations are as speciﬁed in Table 2.
M-I vs. ACIS
 @100% frequency Total @100% frequency
6 5233 29,044 24,014
8 5288 29,541 24,341
2 5130 28,967 23,979
2  5847 30,388 23,889
2 6930 29,724 23,267
4 3884 28,696 23,229
5 5032 24,004 21,905
4 6367 27,593 26,244
3 5781 27,955 23,719
4 84 29,752 25,254
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rom Florida (Okeechobee and Florida). In contrast, there was  no
ariation detected between Florida and Florida relapse strains,
uggesting that the differences observed reﬂected evolutionary
hanges rather than, for example, continuous variation by gene
onversion among pseudogenes. It is known from previous anal-
ses that msp2 and msp3 expression site sequences are different
n Florida and Florida-relapse strains [10,11]. The most conserved
sp2 or msp3 pseudogene was AM1250, absent in only 2/10 strains
xamined (WA-O and OK).
We examined whether the diversity observed in msp2 and
sp3 genes was also reﬂected in differences in SNP proﬁles across
he genome. High conﬁdence differences between the genomes
btained using Roche/454 gsMapper software are shown in Table 3.
gain, few differences were detected between the previous Sanger
nd current Roche/454 data. Only 38 differences (at 100% fre-
uency) were detected in the Florida strain genome and 84 in the St.
aries, Idaho genome by the two sequencing strategies. Similarly,
here were few differences in the Florida relapse strain com-
ared to Florida. Therefore, pyrosequencing data correlated well
ith the previously reported sequences from traditional Sanger
equencing. Comparison of pyrosequencing of the Florida strain
ith the previously reported sequence (CP001079) shows high
onﬁdence differences, possibly due to true SNPs or error, of one
ase per 31,643 nucleotides (at 100% frequency), while compari-
on of pyrosequencing of the St. Maries strain with the previously
eported genome sequence (CP000030) yields a difference of one
ase per 14,258 nucleotides (at 100% frequency). As seen in pre-
ious strain comparisons [27], the number of single nucleotide
olymorphisms (SNPs) between U.S. strains of A. marginale is vari-
ble, from 0.20% to 0.58% of the genome. However, all strains of
. marginale sensu stricto have signiﬁcantly increased numbers of
NPs when compared to the A. marginale subsp. centrale strain,
anging from 1.8% to 2.2%.
ig. 2. Mosaik alignment of pyrosequencing reads with the fully Sanger-sequenced Florida
he  origin of replication in the Florida strain is shown on the x-axis and the individual pyr
sing  Artemis. SNPs are distributed throughout the genomes. (2011) 4923– 4932 4927
To  visualize the location of differences at the entire genome
level, we  utilized the “show SNP marks” feature of Artemis for
visualizing BAM alignments (Fig. 2). The ﬁgure shows the 1/3 of
each genome immediately preceding the origin of replication, with
SNPs in red. The data show that SNPs are distributed across the
genome and agree with Table 3. For example, pyrosequencing data
for Florida and Florida-relapse strains closely resemble the genome
data derived by Sanger-based sequencing. Furthermore, compari-
son of Fig. 2 with Tables 2 and 3 clearly reveals the more closely
related strains to Florida, i.e. Florida-relapse and Virginia and the
more distantly related strains Oklahoma, Washington-O and South
Idaho. These relationships are also seen in both SNP numbers and
in shared msp2 and msp3 pseudogenes. A similar SNP compari-
son of U.S. strains of A. marginale with A. marginale subspecies
centrale (Fig. 3) shows widely distributed SNPs and many gaps
between marginale and centrale where there are no aligning reads.
The locations of these gaps were largely identical for all the U.S. A.
marginale strains, indicating a more distant sequence relationship
between all these strains and the A. marginale subspecies centrale
strain.
3.3. Conservation of genes encoding proposed vaccine antigens
We  next examined the conservation of proposed vaccine anti-
gens from the pfam01617 family, or that have been identiﬁed by
other strategies. These other strategies involved cross-linking of
surface proteins on live organisms by bifunctional reagents, anal-
ysis of T-cell responses of immunized and protected animals and
identiﬁcation of components of the type 4 secretion system rec-
ognized by T cells [14,15,17–19,26]. The data identiﬁed several
proteins in each class that were conserved among all 10 U.S. strains
of A. marginale (Table 4). Interestingly, none were conserved with
A. marginale subspecies centrale. This suggests that relying only on
 strain genome to show SNPs. The approximately one third of the genome preceding
osequencing reads for each comparison strain on the y-axis. SNPs are shown in red
4928 M.J.  Dark et al. / Vaccine 29 (2011) 4923– 4932
F margi
I e strai
a
m
m
w
a
g
g
a
a
s
T
M
aig. 3. A similar comparison to Fig. 2, but of pyrosequencing reads from multiple A. 
n  addition to SNPs throughout the genomes, there are many gaps in all A. marginal
ntigens shared between marginale and centrale may  not be an opti-
al  strategy for development of vaccines against U.S. strains of A.
arginale. Additionally, comparison of the newly sequenced strains
ith the previously sequenced strains showed multiple genes that
re variable in one or more strains; however, no candidate antigen
ene was deﬁned as absent in all the newly sequenced strains. Some
enes, such as omps2, 7, 8 and 15 were more frequently detected as
bsent, whereas others, such as omps10 and 14, were detected as
bsent in only three comparisons between different A. marginale
trains. An example of detailed coverage graphs for omp4 (con-
able 4
osaik/Artemis alignment analysis identiﬁes conserved genes encoding candidate vaccin
Conserved in A. marginale Identiﬁcation
omp1(AM1139) Yes Outer membr
omp4(AM1164) Yes Outer membr
omp6(AM1219)a Yes Outer membr
omp11(AM1255) Yes Outer membr
omp12(AM1257) Yes Outer membr
opag1(AM1143)a Yes Outer membr
opag2(AM1142) Yes Outer membr
opag3(AM1140) Yes Outer membr
msp4(AM090) Yes Outer membr
AM779  Yes Surface X-link
AM780  Yes Surface X-link
pal(AM854)  Yes Surface X-link
purD(AM1011) Yes Surface X-link
virB3(AM815) Yes Type 4 secreti
virB4-1(AM814) Yes Type 4 secreti
virB4-2(AM1053) Yes  Type 4 secreti
virB6(AM811) Yes Type 4 secreti
virB8-1(AM1316) Yes Type 4 secreti
virB9-2(AM1315) Yes Type 4 secreti
virB10(AM1314) Yes Type 4 secreti
virB11(AM1313) Yes  Type 4 secreti
Not expressed.nale strains with the fully Sanger-sequenced A. marginale subspecies centrale strain.
ns where no pyrosequencing reads aligning to centrale are found.
served  in all strains) and omp15 (variable) genes is shown in Fig. 4.
Although omp15 coverage graphs suggest variability of this gene in
most strains, the variability is localized to the C-terminus when all
strains are compared to Florida and to the central region of omp15
when compared to St. Maries. It should also be recognized that
despite their overall conservation and deﬁnition as present, non-
synonymous SNPs are present in most of the candidate antigen
genes (Table 5). There appears to be no trend towards increased
numbers of SNPs or decreased conservation when comparing omps
that are transcribed in either ticks or cattle [33].
e antigens.
 method A. centrale ortholog Conserved between A.
marginale/centrale
ane protein ACIS 00234 No
ane protein ACIS 00227 No
ane protein None No
ane protein ACIS 00140 No
ane protein ACIS 00139 No
ane protein ACIS 00231 No
ane protein ACIS 00232 No
ane protein ACIS 00233 No
ane protein ACIS 01187 No
ing ACIS 00557 No
ing ACIS 00556 No
ing ACIS 00486 No
ing ACIS 00340 No
on ACIS 00521 No
on ACIS 00522 No
on ACIS 00304 No
on ACIS 00526 No
on ACIS 00090 No
on ACIS 00091 No
on ACIS 00092 No
on ACIS 00093 No
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A B
C D
Fig. 4. Genome coverage of pyrosequencing reads over omp15 (A – Florida, B – St. Maries) and omp4 (C – Florida, D – St. Maries) genes from Florida and St. Maries, Idaho
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. Discussion
Development of vaccines against anaplasmosis has received
onsiderable attention over the last 50 years and has resulted in
everal marketed live and inactivated whole-organism vaccines
28]. None are currently available in the U.S. because of varying
fﬁcacy against heterologous strains and/or side-effects such as
soerythrolysis due to contaminating erythrocyte proteins in the
accines. This has stimulated the search for improved vaccines and
lso attempts to understand the reasons for the breaks in vaccine
rotection against heterologous strains [29–31].
The reason for breaks in protection appear to be due to a sophis-
icated system for antigenic variation, whereby the expressed
SP2 and MSP3 outer membrane proteins continually change in
equence [32]. This is caused by segmental gene conversion of
enomic expression sites for MSP2 and MSP3 by genomic pseudo-
enes [10]. The repertoire of pseudogenes determines the ability
f an incoming strain to superinfect a persistently infected car-
ier animal [13]. We  show here that the pseudogene repertoire
s extremely diverse for both MSP2 and MSP3 across the U.S.,
ven within A. marginale strains from the same state. No msp2 or
sp3 pseudogene was present in all U.S. strains. Therefore, it is
nlikely that a vaccine could be developed by trying to include
 full repertoire of potential MSP2/MSP3 variants in a vaccine.
owever, other members of pfam01617 (to which both msp2 and
sp3 belong) encode conserved OMPs and are expressed in A.
arginale [33] and, therefore, still remain viable vaccine candi-
ates.xis. There are no reads aligning with omp15 in many strains over either the 3′ or
Two other vaccine strategies have also been proposed recently.
The ﬁrst [16] relies on the protection afforded by the less viru-
lent strain A. marginale subspecies centrale. This strain has been
extensively used in the ﬁeld in Australia, South Africa, Argentina,
Uruguay, Israel, Zimbabwe and Malawi. Recent research has found
proteins with immunogenic epitopes shared between marginale
and centrale, although the overall protein sequence identities were
less than 90% [16], and these have been proposed for inclusion in
a subunit vaccine. Although A. marginale subsp. centrale undoubt-
edly provides some protection against A. marginale strains [35],
controlled trials have shown low efﬁcacy of this vaccine against
heterologous isolates from South America and Africa [36–39], and
infection by A. marginale subspecies centrale does not prevent
subsequent superinfection by A. marginale [40]. These data have
stimulated the search for less virulent strains of A. marginale to
potentially replace the A. marginale subspecies centrale vaccine, and
such strains have been identiﬁed in Australia and Mexico [41,42].
The  second, recently proposed, vaccine strategy relies on the
observation that immunization with inactivated organisms or outer
membranes can induce sterile protective immunity against chal-
lenge with A. marginale [3,43]. Two  investigations are particularly
noteworthy in this regard: ﬁrstly, the identiﬁcation of the surface
proteome of A. marginale [15,17] and secondly, the identiﬁcation
of type 4 secretion system components recognized by T and B cells
from protected cattle [19]. However, while sterile immunity against
homologous challenge has been achieved, these provide only par-
tial immunity against heterologous challenge. This may  be due to
the immunodominant responses induced against the hypervariable
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Table  5
Total  and non-synonymous SNPs in the pfam01617 superfamily and genes encoding candidate vaccine antigens. SNPs – the number of nucleotide positions in each gene with
high-conﬁdence changes in at least one other strain (excluding gene segments previously deﬁned as absent). NS – the number of SNPs producing a non-synonymous change
in  at least one strain. Ave. Freq. – average frequency of reads with each SNP across all strains. Ave Cov. – average coverage at each SNP nucleotide position.
Florida St. Maries
SNPs NS changes Ave. Freq. Ave. coverage SNPs NS changes Ave. Freq. Ave. coverage
omp1(AM1139) 26 11 99.8 65.8 26 11 99.8 71.9
omp2(AM1156) 1 0 100 12 0 0 N/A N/A
omp3(AM1159) 2 2 100 41 1 1 100 70
omp4(AM1164) 8 2 99.8 43.5 6 0 99.7 58.9
omp5(AM1166) 23 2 99.7 53.9 15 6 99.9 83.2
omp6(AM1219) 5 1 100 68 5 1 90.7 104
omp7(AM1220) 52 11 99.8 13.3  68 27 96.4 33.9
omp8(AM1221) 38 9 93.2  47.2 49 16 96.9 40.4
omp9(AM1222) 32 9 98.3 17.2 31 9 97.7 31.4
omp10(AM1223) 15 10 99.3 35 15 10 99.7 67.9
omp11(AM1255) 26 13 99.8 36 19 10 99.9 30.2
omp12(AM1257) 16 5 99.2 31 17 6 99.3 48.9
omp13(AM1258) 19 8 99.7 21.1 14 5 99.3 70.2
omp14(AM075) 17 7 99.2 75.7 24 12 100 55.1
omp15(AM987) 8 5 100 10.3 4 2 99.3 107.7
opag1(AM1143) 1 0 100 12 2 2 100 160
opag2(AM1142) 4 2 100  77.8 6 4 100 105.2
opag3(AM1140) 43 15 99.8 94.3 43 41 99.8 94.3
msp4(AM090) 8 0 99.8 58.1 9 1 99.1 42.9
AM779  7 1 100.0 37.1 7 1 100.0 37.1
AM780  8 4 96.9 14.1 31 14 99.2 41.7
pal(AM854) 5 3 99.7 60.2 4 2  100.0 58.0
purD(AM1011) 29 1 99.4 42.5 30 1 99.5 48.8
virB3(AM815) 0 0 N/A N/A 0 0 N/A N/A
virB4-1(AM814) 8 1 98.5 37.5 4 1 97.2 18.9
virB4-2(AM1053) 8 1 98.5 37.5 4 1 97.2 18.9
virB6(AM811) 46 26 99.6 36.7 46 25 99.6 39.5
virB8-1(AM1316) 2 0 100 35.3 2 0 100 35
virB9-2(AM1315) 2 0 97.4 45  2 0 97.4 35
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svirB10(AM1314) 5 2 99.9 57
virB11(AM1313) 14 1 99.1 52
SP2 and MSP3 proteins. Compared to these, other antigens, such
s the T4SS proteins and other surface proteome molecules, are
onsidered subdominant antigens. These induce weaker and more
nconsistent antibody and T cell responses, at least in the context
f complex immunogens such as whole organism and membrane
accines that also contain MSP2 and MSP3 [19]. However, while
hese responses may  be less robust, these antigens appear to be less
ariable, making them important to include in a vaccine producing
an-strain immunity.
The  body of previous research in A. marginale has resulted in a
arge catalog of potential vaccine candidates. We  attempted here to
educe the number of candidate antigens by applying high through-
ut genome sequencing and bioinformatics analysis to 10 U.S.
trains of A. marginale. The intent was to identify the most con-
erved proteins from all of the above vaccine strategies that may
orm the core components of a broadly protective vaccine.
We  initially veriﬁed that pyrosequencing was capable of
ccurately determining the relationships among already fully
equenced strains and the variable msp2 and msp3 pseudogenes
n those strains. We  correctly identiﬁed the shared msp2 and msp3
seudogenes and those having <90% identity. This method was  then
pplied to all 10 U.S. strains of A. marginale. Extensive diversity
as observed in the repertoire of both msp2 and msp3 pseudo-
enes among strains, with generally more diversity observed in the
omplement of msp3 pseudogenes when compared to msp2.
There  was also extensive diversity in SNPs among strains,
istributed over most of the genome, agreeing with previous
bservations on a smaller subset of strains [27]. However, the
embers of the pfam01617 family are relatively well conserved
verall, with no protein having <90% identity between all the
trains examined. All of these proteins have SNPs, and SNPs within
trains have a similar distribution pattern to those described for5 2 99.9 51.4
15 1 98.8 46.4
the  rest of the genome in terms of the numbers of strains with
polymorphisms.
A surprising observation was the more extensive diversity in
A. marginale subspecies centrale when compared to all 10 U.S. A.
marginale strains. The taxonomic position of centrale compared to
marginale has been debated previously, with some investigators
proposing a separate species, Anaplasma centrale [44–46]. However,
only a few strains of A. marginale subspecies centrale are available
for analysis. We suggest that resolution of this question should
await genomic data on non-U.S. strains of both marginale and cen-
trale, particularly strains from Africa. This would resolve whether
there is a continuum of strain diversity among marginale strains
eventually reaching that of the single currently sequenced cen-
trale strain, originally isolated by Theiler in South Africa. A recent
study [47] comparing membrane proteins from a Brazilian strain
of A. marginale with Florida and St. Maries determined amino acid
sequence identities of 92–100% for all OMPs investigated except
OMP7, compared to 40–70% identities with the A. marginale sub-
species centrale orthologs. This suggests that the diversity observed
here among U.S. strains of A. marginale may  at least be representa-
tive of marginale strains in North and South America.
Finally, the data reveal the candidate vaccine antigens con-
served among U.S. strains of A. marginale. The catalog includes
conserved members of pfam01617, as well as components of the
bacterial type 4 secretion system and proteins identiﬁed by surface
cross-linking. Interestingly, it does include three proteins iden-
tiﬁed previously that contain epitopes shared with A. marginale
subspecies centrale, namely OMP11 (AM1255), AM779 and AM854
[16]. However, overall the list is broader than just the antigens con-
served between A. marginale sensu stricto and subspecies centrale.
It also eliminates less conserved proteins and housekeeping genes
which share epitopes between centrale and marginale. Additionally,
cine 29
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lthough conserved, OMP6 and OPAG1 can probably be eliminated
rom consideration as vaccine candidates as no expressed peptides
ere detected from the encoding genes in any life cycle stages
n prior studies [33,34]. This revised catalog of 19 antigens (see
able 4) would be readily approachable for synthesis by recombi-
ant expression technology and inclusion in a multi-component
accine for testing. The present genomic data and previous experi-
ental data suggest that such a vaccine may  be efﬁcacious against
.S. strains of A. marginale.
These  data also illustrate the utility of next-generation sequenc-
ng techniques for identiﬁcation of antigens and epitopes conserved
etween multiple strains. While rapid sequencing has been used
xtensively, this study shows its utility in examination of repeti-
ive genes. While these techniques cannot yet assemble a genome
hrough extensive repetitive regions, they can show regions where
here is genetic similarity or where homologous regions are missing
n newly sequenced strains.
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